18th Mar 2024 7:00 am |
RNS |
New research project and CSO to return to academia |
12th Mar 2024 7:00 am |
RNS |
Conversion Notice and Total Voting Rights |
8th Mar 2024 9:43 am |
RNS |
Notice of Results |
28th Feb 2024 12:41 pm |
RNS |
Conversion notice and alternative financing |
27th Feb 2024 7:00 am |
RNS |
Positive Interim AxisBiotix Acne study results |
20th Feb 2024 7:00 am |
RNS |
Dermatonics to launch Once Heel Balm in AMEA |
9th Feb 2024 7:00 am |
RNS |
Conversion Notice and Total Voting Rights |
6th Feb 2024 7:31 am |
RNS |
Dermatonics Full Year trading update |
26th Jan 2024 7:00 am |
RNS |
Completion of Acquisition of Dermatonics |
25th Jan 2024 7:00 am |
RNS |
Acquisition of Dermatonics |
25th Jan 2024 7:00 am |
RNS |
£5.0m Convertible Bond Facility & First Drawdown |
29th Dec 2023 10:49 am |
RNS |
Result of AGM |
29th Dec 2023 8:13 am |
RNS |
Update on transaction timelines to early 2024 |
6th Dec 2023 7:00 am |
RNS |
Notice of AGM and posting of Annual Report |
30th Nov 2023 5:25 pm |
RNS |
Final Results |
30th Nov 2023 7:00 am |
RNS |
AxisBiotix-Psâ„¢ to launch on Amazon UK |
24th Nov 2023 7:00 am |
RNS |
Holding(s) in Company |
23rd Nov 2023 3:37 pm |
RNS |
Holding(s) in Company |
22nd Nov 2023 7:00 am |
RNS |
Update regarding Nominated Adviser and Broker |
21st Nov 2023 7:00 am |
RNS |
Result of Retail Offer |
17th Nov 2023 7:00 am |
RNS |
Result of Placing |
16th Nov 2023 4:35 pm |
RNS |
Retail Offer |
16th Nov 2023 4:33 pm |
RNS |
Placing and Retail Offer |
25th Oct 2023 7:25 am |
RNS |
Acne study, Trading and Auditor updates |
19th Oct 2023 7:00 am |
RNS |
Extension of Croda contract for SkinBiotixâ„¢ |
15th Sep 2023 9:00 am |
RNS |
health authority approval for AxisBiotix in France |
5th Sep 2023 7:00 am |
RNS |
Update on acne programme |
31st Jul 2023 12:51 pm |
RNS |
Holding(s) in Company |
21st Jun 2023 7:00 am |
RNS |
Regulatory Approval |
14th Jun 2023 4:46 pm |
RNS |
Business progress update |
10th May 2023 7:00 am |
RNS |
SkinBiotix and AxisBiotix Update |
14th Apr 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
28th Mar 2023 1:45 pm |
RNS |
Replacement Half-year Report |
28th Mar 2023 7:00 am |
RNS |
Half-year Report |
27th Mar 2023 4:35 pm |
RNS |
Price Monitoring Extension |
9th Mar 2023 5:18 pm |
RNS |
Director/PDMR Shareholding |
9th Mar 2023 5:18 pm |
RNS |
Director/PDMR Shareholding |
7th Mar 2023 7:00 am |
RNS |
AxisBiotix-Ps™ approved for launch in Europe |
20th Feb 2023 11:17 am |
RNS |
Holding(s) in Company |
31st Jan 2023 11:15 am |
RNS |
Result of General Meeting |